Laxmi Dental Q2 FY27 Revenue Rises 10% to ₹79.5 Crore

Laxmi Dental Limited reported Q2 FY27 revenue of ₹79.5 crore, up 10.4% year-on-year, while operating profit rose 38.8% to ₹15.3 crore and EBITDA margin improved to 19.2% from 15.3% a year earlier. The quarterly result reflects stronger growth in its dental laboratory and aligner solutions businesses.

What did Laxmi Dental report for Q2 FY27?

Laxmi Dental reported consolidated sales of ₹79.5 crore for the quarter ended September 30, 2026, compared with ₹72.0 crore in Q2 FY26 and ₹74.7 crore in Q1 FY27. Revenue increased 6.5% sequentially, following the company’s ₹74.7 crore revenue in the preceding quarter.

Operating profit increased to ₹15.3 crore from ₹11.0 crore a year earlier. This lifted the operating profit margin by 392 basis points year-on-year to 19.2%. The margin was unchanged sequentially from Q1 FY27, when operating profit was ₹14.4 crore and the margin was also 19.2%.

The Board approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, on November 3, 2026. The company disclosed consolidated profit after tax of ₹10.04 crore for the quarter, while standalone profit after tax was ₹4.67 crore. The reported consolidated PAT margin was 12.6%.

Other income stood at ₹2.2 crore during the quarter, compared with ₹2.0 crore in Q2 FY26 and ₹2.3 crore in Q1 FY27. The earnings update also noted that reported profit was below the company’s own trend measure, even as core profit grew 37%.

Which businesses drove Laxmi Dental's quarterly growth?

Laxmi Dental said its dental laboratory business grew 22.7% year-on-year in Q2 FY27, while the Aligner Solutions business expanded 23.5%. These growth rates were above the company’s reported revenue increase of 10.4%, indicating that other parts of the business had a lower contribution to overall growth during the quarter.

The dental laboratory business remains central to Laxmi Dental’s operating model. The company has identified digitalisation as an important factor supporting demand, alongside the expansion of its international business. Management said it remains confident about sustained growth from digital adoption and increasing international demand.

The latest quarter followed a stronger year-on-year comparison base. In Q2 FY26, Laxmi Dental had reported 26.5% revenue growth to ₹72.0 crore. In that earlier quarter, the dental laboratory business grew 29.9%, international laboratory business rose 39.2%, and scanner sales increased 94.7%.

Laxmi Dental’s Q1 FY27 result had also shown revenue growth of 13.9% year-on-year to ₹74.7 crore. EBITDA for that quarter was ₹14.4 crore, up 20.6%, while PAT was ₹10.3 crore, up 23.8%. The Q2 result extends the revenue growth trend while maintaining the operating margin achieved in Q1.

How is Laxmi Dental using its IPO proceeds?

Laxmi Dental has redeployed ₹48.1 crore of IPO proceeds towards a new integrated facility. The use of funds links the company’s capital expenditure plans with its stated focus on digitalisation and capacity development across its operations.

As of September 30, 2026, unutilised IPO funds stood at ₹46.76 crore. The company stated that these funds were temporarily parked in fixed deposits. The balance of unutilised funds and the redeployment for the integrated facility are separate disclosures and should be read in the context of the company’s ongoing capital deployment.

The proposed integrated facility is relevant because Laxmi Dental operates in segments where laboratory processes, digital workflows and manufacturing capabilities are important. However, the available filing does not provide a commissioning date, capacity target, project cost, or expected financial contribution from the new facility.

Investors also have a cash-flow consideration alongside the earnings figures. The company’s FY26 operating cash flow was negative despite it reporting a profit. That disclosure makes future cash conversion and the pace of capital expenditure relevant measures when assessing the operating impact of growth investments.

What is the financial context behind the Q2 FY27 result?

Laxmi Dental entered FY27 after revenue growth but lower annual profit in FY26. On a consolidated basis, total income for FY26 was ₹286.40 crore, compared with ₹242.45 crore in FY25. Consolidated profit after tax was ₹28.92 crore, lower than ₹31.83 crore in the previous year.

The company attributed the FY26 profit movement to the impact of US tariffs, geopolitical conditions, higher ESOP expenses and one-time items. On a standalone basis, FY26 total income was ₹216.58 crore versus ₹175.86 crore in FY25, while PAT was ₹19.34 crore against ₹25.78 crore a year earlier.

The Q2 FY27 operating margin of 19.2% is therefore a material improvement from the 15.3% reported in Q2 FY26. Operating profit expanded faster than sales in the latest quarter, with a 38.8% increase against revenue growth of 10.4%.

For investors, the result provides evidence of improved quarterly operating profitability, but it does not by itself resolve the FY26 cash-flow issue or quantify the returns from the planned facility. The pace of segment growth, margin retention and deployment of the remaining IPO funds remain important disclosed operating factors.

How will the Q2 result affect investors and industry operations?

Laxmi Dental’s Q2 FY27 result shows that its two identified growth segments, dental laboratory and Aligner Solutions, expanded more quickly than consolidated revenue. The 19.2% operating margin, which was 392 basis points higher year-on-year, also indicates improved operating profitability compared with the same period last year.

The broader dental services and laboratory ecosystem is becoming more dependent on digital workflows, scanners, aligner products and automation. Laxmi Dental’s comments on digitalisation and international demand place its quarterly performance within that operating context, although the company did not disclose segment revenue or international revenue figures for Q2 FY27.

The company has scheduled an earnings conference call for November 4, 2026, at 10:00 AM IST to discuss its unaudited Q2 FY27 and H1 FY27 results. This forum may provide additional management commentary on segment demand, the integrated facility and capital allocation, but no such additional details were included in the reported results.

Conclusion

Laxmi Dental delivered Q2 FY27 revenue of ₹79.5 crore and operating profit of ₹15.3 crore, with the operating margin rising to 19.2%. Growth in the dental laboratory and Aligner Solutions businesses outpaced overall revenue growth, while quarterly consolidated PAT was ₹10.04 crore.

The next disclosed event is Laxmi Dental’s November 4, 2026 earnings call. Investors will watch for management’s comments on the new integrated facility, the ₹46.76 crore of unutilised IPO funds, international demand and the company’s cash-flow performance.